Literature DB >> 15906168

PEGylation of octreotide: I. Separation of positional isomers and stability against acylation by poly(D,L-lactide-co-glycolide).

Dong Hee Na1, Patrick P DeLuca.   

Abstract

PURPOSE: To investigate the mechanism by which polyethylene glycol (PEG) conjugation (PEGylation) prevents the acylation of octreotide by poly(d,l-lactide-co-glycolide) (PLGA).
METHODS: Octreotide was chemically modified by reaction with succinimidyl propionate-monomethoxy PEG. Each PEGylated octreotide species with different PEG number and modified position was separated by reversed-phase high-performance liquid chromatography (RP-HPLC) and characterized by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) with endoproteinase Lys-C digestion. Acylation of octreotide and PEGylated octreotides was observed with hydrophobic and hydrophilic PLGA.
RESULTS: Two mono- and one di-PEGylated octreotides were separated by RP-HPLC. MALDI-TOF MS of the PEGylated products after Lys-C digestion at different pH revealed that the two mono-PEGylated octreotides were modified at the N-terminus and Lys(5) residue, respectively. The interaction of octreotide with PLGA involved an initial adsorption followed by acylation and the subsequent release of octreotide and acylated octreotide. The initial adsorption of octreotide was dependent on the acidity of PLGA. PEGylation of octreotide significantly inhibited the initial adsorption and acylation by PLGA. In particular, the acylation could be completely prevented by mono-PEGylation at the N-terminus of octreotide.
CONCLUSIONS: This study shows that the N-terminus of octreotide is the preferred PEGylation site to prevent acylation in degrading PLGA microspheres. The mono-N-terminally PEGylated octreotide may possibly serve as a new source for somatostatin microsphere formulation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15906168     DOI: 10.1007/s11095-005-2589-4

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  22 in total

1.  pH and osmotic pressure inside biodegradable microspheres during erosion.

Authors:  A Brunner; K Mäder; A Göpferich
Journal:  Pharm Res       Date:  1999-06       Impact factor: 4.200

Review 2.  Protein instability in poly(lactic-co-glycolic acid) microparticles.

Authors:  M van de Weert; W E Hennink; W Jiskoot
Journal:  Pharm Res       Date:  2000-10       Impact factor: 4.200

3.  In vitro characterization and in vivo testosterone suppression of 6-month release poly(D,L-lactide) leuprolide microspheres.

Authors:  Byung Ho Woo; Kyu-Heum Na; Bhas A Dani; Ge Jiang; B C Thanoo; Patrick P DeLuca
Journal:  Pharm Res       Date:  2002-04       Impact factor: 4.200

4.  Monitoring of peptide acylation inside degrading PLGA microspheres by capillary electrophoresis and MALDI-TOF mass spectrometry.

Authors:  Dong Hee Na; Yu Seok Youn; Sang Deuk Lee; Mi-Won Son; Won-Bae Kim; Patrick P DeLuca; Kang Choon Lee
Journal:  J Control Release       Date:  2003-10-30       Impact factor: 9.776

5.  Optimization of the PEGylation process of a peptide by monitoring with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Authors:  Dong Hee Na; Yu Seok Youn; Kang Choon Lee
Journal:  Rapid Commun Mass Spectrom       Date:  2003       Impact factor: 2.419

6.  Stability of PEGylated salmon calcitonin in nasal mucosa.

Authors:  Dong Hee Na; Yu Seok Youn; Eun Ji Park; Jeong Min Lee; Ock Ryun Cho; Kang Ro Lee; Sang Deuk Lee; Sun Dong Yoo; Patrick P DeLuca; Kang Choon Lee
Journal:  J Pharm Sci       Date:  2004-02       Impact factor: 3.534

7.  Peptide acylation by poly(alpha-hydroxy esters).

Authors:  Andrea Lucke; Josef Kiermaier; Achim Göpferich
Journal:  Pharm Res       Date:  2002-02       Impact factor: 4.200

Review 8.  Octreotide.

Authors:  S W Lamberts; A J van der Lely; W W de Herder; L J Hofland
Journal:  N Engl J Med       Date:  1996-01-25       Impact factor: 91.245

9.  Formation of peptide impurities in polyester matrices during implant manufacturing.

Authors:  A Rothen-Weinhold; N Oudry; K Schwach-Abdellaoui; S Frutiger-Hughes; G J Hughes; D Jeannerat; U Burger; K Besseghir; R Gurny
Journal:  Eur J Pharm Biopharm       Date:  2000-05       Impact factor: 5.571

10.  Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres.

Authors:  K Fu; D W Pack; A M Klibanov; R Langer
Journal:  Pharm Res       Date:  2000-01       Impact factor: 4.200

View more
  24 in total

1.  Reversible blocking of amino groups of octreotide for the inhibition of formation of acylated peptide impurities in poly(lactide-co-glycolide) delivery systems.

Authors:  Jae Hwa Ahn; Eun Ji Park; Hye Suk Lee; Kang Choon Lee; Dong Hee Na
Journal:  AAPS PharmSciTech       Date:  2011-09-21       Impact factor: 3.246

2.  The nature of peptide interactions with acid end-group PLGAs and facile aqueous-based microencapsulation of therapeutic peptides.

Authors:  Andreas M Sophocleous; Kashappa-Goud H Desai; J Maxwell Mazzara; Ling Tong; Ji-Xin Cheng; Karl F Olsen; Steven P Schwendeman
Journal:  J Control Release       Date:  2013-09-08       Impact factor: 9.776

Review 3.  Injectable controlled release depots for large molecules.

Authors:  Steven P Schwendeman; Ronak B Shah; Brittany A Bailey; Anna S Schwendeman
Journal:  J Control Release       Date:  2014-06-12       Impact factor: 9.776

4.  Microcosmic mechanism of dication for inhibiting acylation of acidic Peptide.

Authors:  Feng Qi; Liuqing Yang; Jie Wu; Guanghui Ma; Zhiguo Su
Journal:  Pharm Res       Date:  2015-01-14       Impact factor: 4.200

5.  Reversible hydrophobic ion-paring complex strategy to minimize acylation of octreotide during long-term delivery from PLGA microparticles.

Authors:  Ravi D Vaishya; Abhirup Mandal; Mitan Gokulgandhi; Sulabh Patel; Ashim K Mitra
Journal:  Int J Pharm       Date:  2015-05-01       Impact factor: 5.875

6.  Proton Oriented-"Smart Depot" for Responsive Release of Ca2+ to Inhibit Peptide Acylation in PLGA Microspheres.

Authors:  Jiwei Liu; Yan Xu; Yonglu Wang; Hao Ren; Zhengjie Meng; Kuntang Liu; Zhe Liu; He Huang; Xueming Li
Journal:  Pharm Res       Date:  2019-06-04       Impact factor: 4.200

7.  PEGylation of octreotide: II. Effect of N-terminal mono-PEGylation on biological activity and pharmacokinetics.

Authors:  Dong Hee Na; Kang Choon Lee; Patrick P DeLuca
Journal:  Pharm Res       Date:  2005-05-17       Impact factor: 4.200

Review 8.  Materials for pharmaceutical dosage forms: molecular pharmaceutics and controlled release drug delivery aspects.

Authors:  Heidi M Mansour; Minji Sohn; Abeer Al-Ghananeem; Patrick P Deluca
Journal:  Int J Mol Sci       Date:  2010-09-15       Impact factor: 5.923

9.  Acylation of exenatide by glycolic acid and its anti-diabetic activities in db/db mice.

Authors:  Rongcai Liang; Xiang Li; Renyu Zhang; Yanan Shi; Aiping Wang; Daquan Chen; Kaoxiang Sun; Wanhui Liu; Youxin Li
Journal:  Pharm Res       Date:  2014-02-19       Impact factor: 4.200

10.  Inhibition of peptide acylation in PLGA microspheres with water-soluble divalent cationic salts.

Authors:  Ying Zhang; Andreas M Sophocleous; Steven P Schwendeman
Journal:  Pharm Res       Date:  2009-06-16       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.